Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
ARTIIS
1 other identifier
interventional
113
1 country
1
Brief Summary
The purpose of this study is to investigate the effect of an exercise training intervention on the ability of African American males to use insulin properly. Insulin is a hormone that helps the body use glucose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 5, 2013
CompletedFirst Posted
Study publicly available on registry
February 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2018
CompletedResults Posted
Study results publicly available
October 31, 2024
CompletedOctober 31, 2024
October 1, 2024
2.6 years
February 5, 2013
February 28, 2023
October 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insulin Response to an Oral Glucose Tolerance Test Over 20 Weeks.
An oral glucose tolerance test is a medical test in which glucose is given and blood samples are taken afterward to determine how quickly it is cleared from the blood. The test is usually used to test for diabetes or insulin resistance.
Baseline, week 10, week 20
Secondary Outcomes (8)
Diastolic Blood Pressure
20 weeks
Systolic Blood Pressure
20 weeks
Body Composition
20 weeks
Cardiorespiratory Fitness
20 weeks
Muscular Strength
20 weeks
- +3 more secondary outcomes
Study Arms (2)
Control Group
PLACEBO COMPARATORWe will randomly assign 52 individuals to a no exercise healthy living group.
Aerobic Plus Resistance Training Group
EXPERIMENTALWe will randomly assign 52 individuals to an aerobic plus resistance training group.
Interventions
Participants randomized to this intervention will engage in both aerobic and resistance training in accordance with Physical Activity Guidelines for Americans, that is 150 minutes of aerobic training and 2 days of additional 20 minutes of resistance training. The aerobic training component will be completed on a treadmill and target training intensity will be self-selected at 65% to 85% of maximal aerobic capacity. Each resistance training session will consist of both upper and lower body exercises: 2 sets of 9 exercises with each set consisting of 10 repetitions.
Participants randomized into the control group will not be provided with memberships to any exercise facility, nor will they receive behavioral instruction on how to increase physical activity. They will receive information on living a healthy lifestyle. Such minimal interventions have not been shown to increase physical activity in participants. The participants in this group will undergo the baseline, 10 week, and 20 week testing.
Eligibility Criteria
You may qualify if:
- You completed the three run-in screening visits.
- You self-identify as a male of African descent.
- You are 35 to 70 years of age.
- You have a BMI (ratio of your height to your weight) greater than or equal to 25.0 kg/m2 and less than or equal to 40 kg/m2.
- You have a family history of diabetes.
- You are not currently physically active for 20 minutes each time for 3 or more days per week for the last 6 months. You are not participating in regular muscle building exercise.
- You are willing to give informed consent, willing to be randomized to either the healthy living intervention group or the aerobic plus resistance training exercise group, and willing to follow the protocol for the group to which you have been assigned.
You may not qualify if:
- You drink more than 14 alcoholic drinks per week.
- You plan to move out of the study area within the next 6 months, or plan to be out of the study area for more than 4 weeks during the course of the study.
- You have another member of your household participating in the study.
- You have serious health conditions that would interfere with the intervention goals
- History of cardiovascular disease (CVD) or disorders and are not under the care of a physician to treat the condition, or fail to provide written documentation from your physician indicating that the physician approves of your entering the study
- Have high blood pressure (greater than 155/99 mmHg) and are not under the care of a physician to treat the condition or fail to provide written documentation from your physician indicating that the physician approves of your entering the study
- Have a previous diagnosis of diabetes (Type 1 or 2) or a fasting plasma glucose of \>125 mg/dl
- Have elevated bad cholesterol (greater than or equal to 190mg/dl) or triglycerides (great than or equal to 300) and are not under the care of a physician to treat the condition or fail to provide written documentation from your physician indicating that the physician approves of you entering the study
- Are currently taking medications for diabetes or chronic steroid use
- Have chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological or psychiatric conditions
- Have had cancer requiring treatment in the past 5 years, expect for non-melanoma skin cancers or cancers that have clearly been cured or in the option of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer)
- Have autoimmune or collagen vascular diseases
- Have immunodeficiency diseases or HIV
- You have any other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator are life-threatening or that may interfere with study participation or the ability to follow the intervention protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Related Publications (2)
Newton RL Jr, Johnson WD, Hendrick C, Harris M, Andrews E 3rd, Johannsen N, Rodarte RQ, Hsia DS, Church TS. A randomized controlled exercise training trial on insulin sensitivity in African American men: The ARTIIS study: Major category: study design, statistical design, study protocols. Contemp Clin Trials. 2015 Jul;43:75-82. doi: 10.1016/j.cct.2015.05.004. Epub 2015 May 12.
PMID: 25979318BACKGROUNDNewton RL Jr, Johnson WD, Larrivee S, Hendrick C, Harris M, Johannsen NM, Swift DL, Hsia DS, Church TS. A Randomized Community-based Exercise Training Trial in African American Men: Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men. Med Sci Sports Exerc. 2020 Feb;52(2):408-416. doi: 10.1249/MSS.0000000000002149.
PMID: 31939911BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Robert Newton
- Organization
- Pennington Biomedical Research Center
Study Officials
- PRINCIPAL INVESTIGATOR
Robert L. Newton, PhD
Pennington Biomedical Research Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 5, 2013
First Posted
February 8, 2013
Study Start
December 1, 2012
Primary Completion
July 1, 2015
Study Completion
March 31, 2018
Last Updated
October 31, 2024
Results First Posted
October 31, 2024
Record last verified: 2024-10